CNS launches custom-fit regulatory consulting service

By Natalie Morrison

- Last updated on GMT

Related tags Molecular biology

Clinical Network Services (CNS) has launched its new custom-fit regulatory consulting service, BioDesk.

The Australian CRO (contract research organisation) says its new offering – geared towards Phase I & II trials – is made up of an international, multi-disciplinary network of preclinical and regulatory consultants.

The company will then tailor the “ideal team” to suit each project, who will work with clients from product profiling right up to support finding investors.

Russell Neal, chief operating officer of CNS, told Outsourcing-Pharma that the level of service they can provide is unique for a company in Australia or New Zealand.

He added: Our service works because it is a sum of the parts.

For CNS’s clients, who are smaller with fewer internal resources, it is critical for them to establish trusted consultant relationships and gain applicable and strategic international regulatory advice for their programs.

“We can relate to target plans small company to small company.”

Services for all

With the appointment of gene therapy and genetically modified organisms (GMOs) expert Mark Reid, who will become the leader of the new service offering, Outsourcing-Pharma put the question to Neal whether the company would specialize in this field.

“No - we haven’t specialised, nor will we,”​ he replied.

“We provide services to all therapeutic areas and technologies. However, Mark does bring rare insight and experience to gene therapy and biological in general. “

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us


View more